Metropolitan Life Insurance Company (MetLife)’s Cognizant CTSH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,085	Closed	-$1.47M	–	533
2024 Q1	$1.47M	Sell	20,085 -324	-2%	-$24.8K	0.06%	258
2023 Q4	$1.54M	Sell	20,409 -486	-2%	-$33.6K	0.07%	232
2023 Q3	$1.42M	Sell	20,895 -1,220	-6%	-$84.2K	0.07%	236
2023 Q2	$1.44M	Sell	22,115 -651	-3%	-$40.3K	0.07%	247
2023 Q1	$1.39M	Sell	22,766 -6,957	-23%	-$436K	0.07%	252
2022 Q4	$1.7M	Sell	29,723 -1,102	-4%	-$64.6K	0.08%	255
2022 Q3	$1.77M	Sell	30,825 -565	-2%	-$37K	0.08%	235
2022 Q2	$2.12M	Sell	31,390 -1,024	-3%	-$78.4K	0.09%	208
2022 Q1	$2.91M	Sell	32,414 -27,657	-46%	-$2.43M	0.1%	184
2021 Q4	$5.33M	Sell	60,071 -1,188	-2%	-$95.5K	0.07%	216
2021 Q3	$4.55M	Sell	61,259 -2,282	-4%	-$168K	0.07%	232
2021 Q2	$4.4M	Sell	63,541 -3,401	-5%	-$253K	0.06%	250
2021 Q1	$5.23M	Sell	66,942 -3,805	-5%	-$294K	0.08%	197
2020 Q4	$5.8M	Sell	70,747 -5,442	-7%	-$414K	0.09%	180
2020 Q3	$5.29M	Sell	76,189 -3,134	-4%	-$204K	0.09%	178
2020 Q2	$4.51M	Sell	79,323 -5,564	-7%	-$299K	0.08%	198
2020 Q1	$3.94M	Sell	84,887 -412	-0.5%	-$24.6K	0.08%	200
2019 Q4	$5.29M	Sell	85,299 -468	-0.5%	-$28.9K	0.08%	204
2019 Q3	$5.17M	Sell	85,767 -26,027	-23%	-$1.65M	0.09%	206
2019 Q2	$7.09M	Buy	111,794 +3,849	+4%	+$253K	0.12%	151
2019 Q1	$7.82M	Sell	107,945 -3,915	-3%	-$274K	0.14%	124
2018 Q4	$7.1M	Buy	111,860 +968	+0.9%	+$67.3K	0.14%	125
2018 Q3	$8.56M	Sell	110,892 -3,379	-3%	-$264K	0.14%	124
2018 Q2	$9.03M	Sell	114,271 -2,443	-2%	-$192K	0.15%	123
2018 Q1	$9.4M	Buy	116,714 +325	+0.3%	+$25.7K	0.13%	119
2017 Q4	$8.27M	Sell	116,389 -189,233	-62%	-$13.8M	0.11%	137
2017 Q3	$22.2M	Sell	305,622 -3,588	-1%	-$252K	0.14%	129
2017 Q2	$20.5M	Sell	309,210 -15,625	-5%	-$993K	0.14%	134
2017 Q1	$19.3M	Sell	324,835 -3,619	-1%	-$208K	0.13%	140
2016 Q4	$18.4M	Sell	328,454 -8,236	-2%	-$441K	0.13%	145
2016 Q3	$16.1M	Sell	336,690 -3,664	-1%	-$208K	0.12%	162
2016 Q2	$19.5M	Sell	340,354 -5,224	-2%	-$316K	0.14%	134
2016 Q1	$21.7M	Sell	345,578 -4,127	-1%	-$240K	0.17%	114
2015 Q4	$21M	Sell	349,705 -5,018	-1%	-$323K	0.16%	122
2015 Q3	$22.2M	Sell	354,723 -6,596	-2%	-$414K	0.16%	119
2015 Q2	$22.1M	Buy	361,319 +3,175	+0.9%	+$199K	0.16%	134
2015 Q1	$22.3M	Sell	358,144 -4,115	-1%	-$243K	0.16%	129
2014 Q4	$19.1M	Sell	362,259 -754	-0.2%	-$37.7K	0.13%	153
2014 Q3	$16.3M	Sell	363,013 -6,149	-2%	-$289K	0.12%	172
2014 Q2	$18.1M	Sell	369,162 -16,137	-4%	-$787K	0.13%	165
2014 Q1	$19.5M	Sell	385,299 -4,547	-1%	-$227K	0.14%	150
2013 Q4	$19.7M	Sell	389,846 -6,226	-2%	-$284K	0.14%	147
2013 Q3	$16.3M	Sell	396,072 -3,464	-0.9%	-$129K	0.12%	154
2013 Q2	$12.5M	Buy	+399,536	New	+$13.3M	0.1%	205

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTSH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cognizant (CTSH) in Q2 2024, closing a stake of 20,085 shares — an estimated $1.47M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTSH in Q2 2013 and held it in 44 quarters. The position peaked at $22.3M in Q1 2015. 904 funds tracked by Wall St. Rank hold CTSH as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Cognizant position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 20,085 Cognizant shares in Q2 2024, an estimated $1.47M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Cognizant in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Cognizant position peaked at $22.3M in Q1 2015.
904 funds tracked by Wall St. Rank held Cognizant as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.